RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.

Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including TwitterLinkedIn and Facebook.

Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Zachary Brousseau, senior manager of communications, at zbrousseau@raps.org or by calling +301 770 2920 ext. 245.

Press Releases

RAPS Euro Convergence draws participants from 32 countries to hear from European regulatory experts

Posted 12 May 2021 | By Zachary Brousseau 

RAPS Euro Convergence 2021, the premier annual event for European regulatory professionals, wrapped up today after three days of online education sessions, expert presentations and panel discu...

RAPS Euro Convergence: A preview

Posted 06 May 2021 | By Zachary Brousseau 

RAPS will hold its annual RAPS Euro Convergence conference devoted to European healthcare product regulations and regulatory issues, 10–12 May. This year’s program will feature more than 130 e...

138 Global Professionals Earn Regulatory Affairs Certification (RAC) in Autumn 2020

Posted 09 March 2021 | By Zachary Brousseau 

RAPS announced today the names of 138 individuals who passed Regulatory Affairs Certification (RAC) exams last autumn.

180 Passed RAC Exams This Summer

Posted 05 November 2020 | By Zachary Brousseau 

RAPS announced today that 180 regulatory professionals passed the Regulatory Affairs Certification (RAC) exam during the summer 2020 exam period.

RAPS' virtual Euro Convergence 'provides needed forum' for European regulatory pros

Posted 30 October 2020 | By Zachary Brousseau 

RAPS' weeklong 2020 Euro Convergence wrapped up today, fittingly concluding with a session devoted to the impact of the COVID-19 pandemic on the future of regulatory. The profound effects of t...

RAPS in the News

FDA delays collecting drugmaker data required by CARES Act | Becker's ASC Review

Posted 26 August 2020 | By Maia Anderson

...new data required from drugmakers under the Coronavirus Aid, Relief, and Economic Security Act next month, though the measure is set to take effect Sept. 23, Regulatory Focus reported.

V is for vaccine | The Star

Posted 22 August 2020

According to Regulatory Affairs Professional Society (RAPS), it will take a fast-tracked vaccine development anywhere between 12 and 18 months to be marketed commercially...

Pfizer Eyes Vaccine Race Finish Line | Investopedia

Posted 21 August 2020 | By Deborah D'Souza

Source: Regulatory Affairs Professionals Society...

FDA publicizes 20 device shortages, 1 discontinuation | Becker's ASC Review

Posted 17 August 2020 | By Angie Stewart

...required to notify the FDA of events that could disrupt the supply of a device during the public health emergency, according to the Regulatory Affairs Professionals Society.

The European Commission has reached a first agreement with AstraZeneca to purchase a potential vaccine against covid-19. | Delano

Posted 15 August 2020 | By Jess Bauldry

...19 vaccines are being developed around the world, according to the Regulatory Affairs Professional Society. Currently ...

  • 1
  • 2